PrashantKumar Khirsariya, Ph.D., M.Sc.
Researcher II, Department of Chemistry
Total number of publications: 28
2018
-
Selective CHK1 inhibitor MU380 exhibits single-agent activity against chronic lymphocytic leukemia cells with TP53 mutations
Year: 2018, type: Conference abstract
2017
-
Diastereoselective Flexible Synthesis of Carbocyclic C Nucleosides
The Journal of Organic Chemistry, year: 2017, volume: 82, edition: 7, DOI
-
Flow cytometric analysis of nucleoside transporters activity
Year: 2017, type: Conference abstract
-
Chk1 Inhibitor SCH900776 Effectively Potentiates the Cytotoxic Effects of Platinum-Based Chemotherapeutic Drugs in Human Colon Cancer Cells
Neoplasia, year: 2017, volume: 19, edition: 10, DOI
-
Structural Basis of the Interaction of Cyclin-Dependent Kinase 2 with Roscovitine and Its Analogues Having Bioisosteric Central Heterocycles
ChemPhysChem, year: 2017, volume: 18, edition: 7, DOI
-
Synthesis and Profiling of a Novel Potent Selective Inhibitor of CHK1 Kinase Possessing Unusual N-trifluoromethylpyrazole Pharmacophore Resistant to Metabolic N-dealkylation
Molecular Cancer Therapeutics, year: 2017, volume: 16, edition: 9, DOI
2016
-
Development and validation of a highly sensitive LC-MS method for determination of checkpoint kinase 1 inhibitors in mouse plasma
Advances in chromatography and electrophoresis & Chiranal 2016, year: 2016
2015
-
Chronic lymphocytic leukemia cells are highly susceptible to direct inhibition of checkpoint kinase
Year: 2015, type: Conference abstract